DHMRI and Metabolon Announce Strategic Partnership to Provide Expanded Metabolomics Capabilities


DHMRI and Metabolon Announce Strategic Partnership to Provide Expanded Metabolomics Capabilities

KANNAPOLIS & RESEARCH TRIANGLE PARK, N.C. (August 27, 2013) – The David H. Murdock Research Institute (DHMRI) at the North Carolina Research Campus and Metabolon, Inc.,  announced today that they have entered into a strategic agreement to align metabolomics research services. Metabolon is a pioneering leader in discovery metabolomics and specializes in rapidly assessing metabolism in biological samples to quickly identify prospective biomarkers and to understand metabolic effects of treatments, interventions, nutritionals, etc. The agreement complements DHMRI’s mass spectrometry and NMR-based metabolomics services through access to Metabolon’s industry-leading high-throughput biomarker discovery and profiling platform which provides an extensive, untargeted, broad metabolite survey of more than 4000 biochemicals.

“This agreement leverages the strengths of our organizations to best serve DHMRI collaborators to understand metabolism and ultimately answer key research questions and deliver healthy food products for consumers. We have worked extensively in food science and nutrition and recognize that our combined resources are indeed complementary. DHMRI is a center of excellence in nutrition research and we are delighted to do our part to meet their growing needs,” says Chris Bernard, Senior Vice President of Sales & Marketing for Metabolon.

DHMRI is an established not-for-profit research institute that provides flexible, client-focused research services to academia, government and industry collaborators.  This agreement, consistent with the DHMRI’s collaborative approach to scientific inquiry, provides partners with additional resources for metabolomics.  Metabolon’s global metabolomic approach can pinpoint active pathways which can be further interrogated by targeted and or customized approaches offered by the DHMRI Metabolomics team.

“We are excited to broaden the breadth of services offered by the DHMRI to our collaborators. The benefits stemming from the collective knowledge of our organizations will be readily realized by researchers, companies and consumers,” said Steve Lommel, Ph.D., Interim President, David H. Murdock Research Institute.

About David H. Murdock Research Institute
The David H. Murdock Research Institute (DHMRI) is a not-for-profit, research institute committed to the improvement of human life. DHMRI provides collaborators groundbreaking research and development solutions at the intersection of human health, nutrition and agriculture through investigations in genomics, proteomics, metabolomics, NMR, light microscopy and cell biology. DHMRI combines collaboration and customized solutions with a multidisciplinary, systems biology approach to find answers to advance research and product development. To learn more, please visit or contact

About Metabolon
About Metabolon, Inc. is a world leader in the field of metabolomics by pioneering and patenting the industry’s leading biochemical biomarker discovery and profiling platform. It has developed the technology to quickly identify and measure the biochemicals in a biological sample through its proprietary global processing method. Metabolon has a broad pipeline of diagnostic products in the fields of obesity-related conditions and cancer. Quantose™ is the first diagnostic test developed by Metabolon using its technology. Metabolon’s expertise is embraced by a wide range of pharmaceutical, biotechnology, food and agricultural companies. Metabolytics, its biomarker discovery and analysis business, has completed over 3,000 client studies with more than 550 customers. For more information about Metabolon, please visit or contact Matt Zaske at 919-595-2200 or
Media Contact:
Mackenzie Mills
SpecOps Communications
212.518.7721 Ph.
913.558.2492 Cell

Benjamin D. Machon
David H Murdock Research Institute